Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MAP-ID

Financiado

Cerrado

Multilevel approaches to understanding chronic inflammatory diseases.

The MAP-ID project aims to deliver an East-West Europe-integrating training programme for PhD students, focused on tackling one of the most challenging, complex, and therapeutically unmet problems which are chronic inflammatory di... ver más

31/03/2030

UNIWERSYTET JAGIEL...

Presupuesto desconocido

Líder del proyecto

UNIWERSYTET JAGIELLONSKI No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto

HORIZON-MSCA-2023-COFUND-01-01: MSCA COFUND 2023 ExpectedOutcome:Projects results are expected to contribute to the following outcomes:

I+D

Cerrada hace 11 meses

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

UNIWERSYTET JAGIELLONSKI

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

INFLANET Training European Experts in Inflammation from the molecula... 4M€ Cerrado

GACD3 Global Alliance for Chronic Diseases Secretariat 377K€ Cerrado

PID2020-116709RB-I00 CARACTERIZACION DE LA PIROPTOSIS INDUCIDA POR GASDERMINAS EN... 435K€ Cerrado

COSMIC COmbatting disorders of adaptive immunity with Systems MedIC... 4M€ Cerrado

ExpoBiome Deciphering the impact of exposures from the gut microbiome... 2M€ Cerrado

GACD Global Alliance for Chronic Diseases Secretariat 240K€ Cerrado

Duración del proyecto: 59 meses Fecha Inicio: 2025-04-01
Fecha Fin: 2030-03-31

Líder del proyecto

UNIWERSYTET JAGIELLONSKI No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The MAP-ID project aims to deliver an East-West Europe-integrating training programme for PhD students, focused on tackling one of the most challenging, complex, and therapeutically unmet problems which are chronic inflammatory diseases. MAP-ID will train chronic inflammation-oriented researchers to become leaders in the field in regional, national, and international arenas. Within the doctoral programme, 13 DCs will conduct their research under the supervision of prominent specialists from the Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University in Poland (JU), in collaboration with international partner academic institutions and biotech companies. MAP-ID focuses on multilevel approaches to understanding chronic inflammatory diseases, including infectious, autoimmune, allergic disorders, and cancer. To achieve this goal, the programme will establish and strengthen ties and collaborations between JU and top Universities and non-academic partners in Europe and beyond. MAP-ID aims to foster interdisciplinary research spanning molecular, cell, and structural biology, biophysics, chemistry, pharmaceutical sciences, and bioinformatics with a significant contribution of OMICS data sets. The training will give the DCs a detailed insight into the strategies and mechanisms required to contribute to growth in the sector of academic and industrial research related to chronic inflammatory disease research and development. The training will include courses conducted by both host institution researchers and visiting scientists from world-leading Universities and companies. Some of the courses offered for DCs, created specifically for MAP-ID, will be accessible to other JU researchers, enriching the learning resources available to them. Therefore, the MAP-ID will have a significant impact on the JU community and its public image, enabling JU to strengthen its position as a leader in chronic inflammation-related research in central Europe.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores